Geneos Wealth Management’s XPeng XPEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-80
Closed -$614 – 2188
2024
Q1
$614 Buy
+80
New +$776 ﹤0.01% 2105
2023
Q2
– Sell
-375
Closed -$4.17K – 2125
2023
Q1
$4.17K Hold
375
– – ﹤0.01% 1773
2022
Q4
$3.73K Hold
375
– – ﹤0.01% 1776
2022
Q3
$4K Sell
375
-600
-62% -$12.9K ﹤0.01% 1757
2022
Q2
$29K Hold
975
– – ﹤0.01% 1518
2022
Q1
$26K Hold
975
– – ﹤0.01% 1683
2021
Q4
$49K Hold
975
– – ﹤0.01% 1491
2021
Q3
$34K Hold
975
– – ﹤0.01% 1677
2021
Q2
$42K Sell
975
-150
-13% -$5.11K ﹤0.01% 1567
2021
Q1
$33K Hold
1,125
– – ﹤0.01% 1836
2020
Q4
$36K Buy
+1,125
New +$41.3K ﹤0.01% 1618

Other funds holding XPEV

Geneos Wealth Management's XPEV Position: Q2 2024 in Review

Geneos Wealth Management sold out of XPeng (XPEV) in Q2 2024, closing a stake of 80 shares — an estimated $614 sold.

Geneos Wealth Management first reported a position in XPEV in Q4 2020 and held it in 11 quarters. The position peaked at $49K in Q4 2021. 189 funds tracked by Wall St. Rank hold XPEV as of Q2 2024.

  • Geneos Wealth Management reported no remaining XPeng position as of Q2 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 80 XPeng shares in Q2 2024, an estimated $614.
  • Geneos Wealth Management first reported a position in XPeng in Q4 2020 and held it in 11 quarters.
  • Geneos Wealth Management's XPeng position peaked at $49K in Q4 2021.
  • 189 funds tracked by Wall St. Rank held XPeng as of Q2 2024.

Based on Geneos Wealth Management's 13F filing for Q2 2024, filed 23 Jul 2024.